Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 3Terminated 2Not yet recruiting 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 47Head & Neck 5Thoracic 2Endocrine 2Tumor-Agnostic 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Carcinoma, Neuroendocrine 2

Interventions

Observation 2Interviews as Topic 2Fluorouracil 2Carboplatin 2Adrenalectomy 2zimberelimab 1trametinib 1lutetium Lu 177 dotatate 1dabrafenib 1cemiplimab 1apatinib 1anlotinib 1Watchful Waiting 1Thyroxine 1Surveys and Questionnaires 1Standard of Care 1Radiomics 1Radiation 1Positron Emission Tomography Computed Tomography 1Mitoxantrone 1Leucovorin 1Irinotecan 1Injections 1IFL protocol 1Etoposide 1Engineering 1Endoscopic Mucosal Resection 1Decision Support Techniques 1Counseling 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Fluorouracil × Endocrine × Clear all
NCT07595913 2026-05-19

A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine Carcinoma

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Phase 3 Not yet recruiting
240 enrolled
Endocrine

Carcinoma, Neuroendocrine

NCT07014540 2025-06-11

A Irinotecan Liposome Trial of in Advanced Neuroendocrine Carcinoma

Beijing GoBroad Hospital

Phase 4 Not yet recruiting
45 enrolled
Endocrine

Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡